0001140361-16-070687.txt : 20160623 0001140361-16-070687.hdr.sgml : 20160623 20160623175249 ACCESSION NUMBER: 0001140361-16-070687 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160621 FILED AS OF DATE: 20160623 DATE AS OF CHANGE: 20160623 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Relypsa Inc CENTRAL INDEX KEY: 0001416792 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 260893742 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100 CARDINAL WAY CITY: REDWOOD CITY STATE: CA ZIP: 94063 BUSINESS PHONE: 650-421-9500 MAIL ADDRESS: STREET 1: 100 CARDINAL WAY CITY: REDWOOD CITY STATE: CA ZIP: 94063 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SPIEGELMAN DANIEL K CENTRAL INDEX KEY: 0001238403 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36184 FILM NUMBER: 161729445 MAIL ADDRESS: STREET 1: 3172 PORTER DRIVE CITY: PALO ALTO STATE: CA ZIP: 94034 4 1 doc1.xml FORM 4 X0306 4 2016-06-21 0 0001416792 Relypsa Inc RLYP 0001238403 SPIEGELMAN DANIEL K C/O RELYPSA, INC. 100 CARDINAL WAY REDWOOD CITY CA 94063 1 0 0 0 Common Stock 2016-06-21 4 A 0 2250 0.00 A 3487 D Stock Option (Right to Buy) 17.00 2016-06-21 4 A 0 4500 0.00 A 2026-06-20 Common Stock 4500 4500 D Restricted Stock Units ("RSUs"). The Reporting Person is entitled to receive one (1) share of Common Stock for each one (1) RSU upon vesting. 100% of the RSUs shall vest on the earlier of (i) June 21, 2017 or (ii) immediately prior to the next annual meeting of the Issuer's stockholders, subject to the Reporting Person continuing in service on the Issuer's Board of Directors through such vesting date. Includes 2,250 RSUs. 100% of the shares subject to the option shall vest and become exercisable on the earlier of (i) June 21, 2017 or (ii) immediately prior to the next annual meeting of the Issuer's stockholders, subject to the Reporting Person continuing in service on the Issuer's Board of Directors through such vesting date. /s/ Ronald A. Krasnow, as Attorney-in-Fact for Daniel K. Spiegelman 2016-06-23